Equifax (NYSE:EFX – Get Free Report) will be posting its quarterly earnings results after the market closes on Wednesday, October 16th. Analysts expect Equifax to post earnings of $1.82 per share for the quarter. Individual that wish to listen to the company’s earnings conference call can do so using this link.
Equifax (NYSE:EFX – Get Free Report) last issued its earnings results on Wednesday, July 17th. The credit services provider reported $1.82 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.73 by $0.09. Equifax had a return on equity of 18.88% and a net margin of 10.67%. The firm had revenue of $1.43 billion for the quarter, compared to analysts’ expectations of $1.42 billion. During the same period in the previous year, the firm posted $1.71 earnings per share. The business’s revenue was up 8.6% compared to the same quarter last year. On average, analysts expect Equifax to post $7 EPS for the current fiscal year and $10 EPS for the next fiscal year.
Equifax Trading Up 0.5 %
Shares of EFX stock opened at $285.20 on Monday. Equifax has a 12-month low of $159.95 and a 12-month high of $309.63. The company has a current ratio of 0.79, a quick ratio of 0.79 and a debt-to-equity ratio of 1.01. The stock’s 50-day moving average price is $294.15 and its 200-day moving average price is $262.16. The stock has a market capitalization of $35.25 billion, a price-to-earnings ratio of 63.52, a price-to-earnings-growth ratio of 2.00 and a beta of 1.58.
Equifax Announces Dividend
Analyst Upgrades and Downgrades
Several equities research analysts have weighed in on EFX shares. Robert W. Baird boosted their price objective on Equifax from $260.00 to $290.00 and gave the stock an “outperform” rating in a research note on Friday, July 19th. Wolfe Research started coverage on Equifax in a research note on Tuesday, July 9th. They set an “outperform” rating and a $275.00 price objective on the stock. Stifel Nicolaus boosted their price objective on Equifax from $265.00 to $305.00 and gave the stock a “buy” rating in a research note on Friday, July 19th. BNP Paribas raised Equifax from an “underperform” rating to a “neutral” rating and set a $310.00 price objective on the stock in a research note on Thursday, September 19th. Finally, UBS Group assumed coverage on Equifax in a research note on Tuesday, October 1st. They set a “buy” rating and a $360.00 price objective on the stock. Four investment analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $307.74.
Check Out Our Latest Analysis on Equifax
Insider Buying and Selling
In related news, EVP Carla Chaney sold 3,000 shares of the business’s stock in a transaction that occurred on Wednesday, August 7th. The shares were sold at an average price of $281.85, for a total value of $845,550.00. Following the completion of the transaction, the executive vice president now owns 10,875 shares of the company’s stock, valued at $3,065,118.75. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 1.57% of the stock is currently owned by insiders.
Equifax Company Profile
Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.
Featured Articles
- Five stocks we like better than Equifax
- Energy and Oil Stocks Explained
- Why Fastenal Stock Could Hit New Highs After Strong Q3 Results
- 3 REITs to Buy and Hold for the Long Term
- Why Eli Lilly Stock Is Soaring—and How It Plans to Stay on Top
- Low PE Growth Stocks: Unlocking Investment Opportunities
- 3 Mid-Cap Stocks Under $20 With Insider Buying and Major Upside
Receive News & Ratings for Equifax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Equifax and related companies with MarketBeat.com's FREE daily email newsletter.